Which way forward for treatment of severe ocular inflammation?

Lightman, Sue; McCluskey, Peter J

Lightman, Sue; McCluskey, Peter J.

Clin Exp Ophthalmol ; 34(4): 293-4, 2006.

Article in En | MEDLINE | ID: mdl-16764644

Subject(s)

Anti-Inflammatory Agents/therapeutic use; Immunosuppressive Agents/therapeutic use; Uveitis/drug therapy; Anti-Inflammatory Agents/economics; Antibodies, Monoclonal/economics; Antibodies, Monoclonal/therapeutic use; Drug Costs; Glucocorticoids/economics; Glucocorticoids/therapeutic use; Humans; Immunosuppressive Agents/economics; Inflammation/drug therapy; Inflammation/economics; Infliximab; Interferon-alpha/economics; Interferon-alpha/therapeutic use; Triamcinolone Acetonide/economics; Triamcinolone Acetonide/therapeutic use; Uveitis/economics

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Uveitis / Immunosuppressive Agents / Anti-Inflammatory Agents Limits: Humans Language: En Journal: Clin Exp Ophthalmol Journal subject: OFTALMOLOGIA Year: 2006 Document type: Article Country of publication: Australia

Search on Google

Add to My VHL

XML

PubMed Links